Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 29 Jan 2025

Interpretable machine learning and radiomics in hip MRI diagnostics: comparing ONFH and OA predictions to experts

in Cancer Immunity and Immunotherapy

Tariq Alkhatatbeh
Ahmad Alkhatatbeh
Qin Guo
Jiechen Chen
Jidong Song
Xingru Qin
Wang Wei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532248

581 views

Original Research

Published on 29 Jan 2025

SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Pengzhou Kong
Ye Jiao
Meng Sun
Zhinan Zhou
Yingying Zhang
Xin Yang
Jing Ren
Mengyuan Yang
Yanyan Dong
Bin Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1507227

655 views

Editorial

Published on 29 Jan 2025

Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II

in Cancer Immunity and Immunotherapy

Junjiang Fu
Luca Antonioli
Xiaoli Zheng
Ali H. El-Far

Frontiers in Immunology

doi 10.3389/fimmu.2025.1538930

453 views

Original Research

Published on 29 Jan 2025

Peripheral blood immunoinflammatory biomarkers: prospective predictors of postoperative long-term survival and chronic postsurgical pain in breast cancer

in Cancer Immunity and Immunotherapy

Baoli Li
Li Che
Huixian Li
Fangdi Min
Bolun Ai
Linxin Wu
Taihang Wang
Peixin Tan
Bingbing Fu
Jiashuo Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531639

514 views

Review

Published on 29 Jan 2025

Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development

in Cancer Immunity and Immunotherapy

Zhangmin Ke
Kaikai Shen
Li Wang
Hao Xu
Xia Pan
Zhenjue Qian
Yuting Wen
Tangfeng Lv
Xiuwei Zhang
Yong Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531246

782 views

Original Research

Published on 29 Jan 2025

Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer

in Cancer Immunity and Immunotherapy

Shuwen Dong
Anqi Li
Ruixin Pan
Jin Hong
Zheng Wang
Kunwei Shen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1522149

546 views

Case Report

Published on 29 Jan 2025

Sinonasal small-cell carcinoma combined concurrently with small-cell lung carcinoma: case report and literature review

in Cancer Immunity and Immunotherapy

Rencui Quan
Ling Han
Shihai Wu
Xianming Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1457907

619 views

Review

Published on 29 Jan 2025

Recent advances in the role of high-salt diet in anti- and pro-cancer progression

in Cancer Immunity and Immunotherapy

Shiwei Tang
Juan Xu
Ping Wan
Shumen Jin
Ying Zhang
Linting Xun
Jinli Wang
Mei Luo
Wenjie Chen
Zan Zuo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1542157

694 views

Original Research

Published on 29 Jan 2025

Radiomics-based biomarker for PD-1 status and prognosis analysis in patients with HCC

in Cancer Immunity and Immunotherapy

Gulizaina Hapaer
Feng Che
Qing Xu
Qian Li
Ailin Liang
Zhou Wang
Jituome Ziluo
Xin Zhang
Yi Wei
Yuan Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1435668

484 views

Clinical Trial

Accepted on 28 Jan 2025

Neoadjuvant Sintilimab and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial

in Cancer Immunity and Immunotherapy

Jincheng Guo
Chengrui Qiao
Jiabin Lu
Shiqing Yang
Boyi Zhang
Dongxia Tang
Hui Pang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1486275

Review

Accepted on 28 Jan 2025

Prospect of Extracellular Vesicles in Tumor Immunotherapy

in Cancer Immunity and Immunotherapy

Wenbo Xia
Yunhan Tan
Yongen Liu
Na Xie
Huili Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1525052

Original Research

Published on 28 Jan 2025

Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation

in Cancer Immunity and Immunotherapy

Lei Sun
Jinhao Zhang
Zhikai Xiahou
Zhenzhen Zhao
Yanchen Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506225

870 views

Case Report

Published on 28 Jan 2025

Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Youjia Li
Kai Qu
Xiuli Li
Xin Yang
Kanghuai Zhang
Jiao Xie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1505195

616 views

Original Research

Published on 28 Jan 2025

A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer

in Cancer Immunity and Immunotherapy

Luis Munoz-Erazo
Saem Mul Park
Shelly Lin
Chun-Jen J. Chen
Lisa Y. Y. Zhou
Janet L. Rhodes
Taesung Jeon
Sonya Fenton
John L. McCall
Roslyn A. Kemp

Frontiers in Immunology

doi 10.3389/fimmu.2025.1500792

432 views

Systematic Review

Published on 27 Jan 2025

Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Huan Zhang
Jing Huang
Huanji Xu
Nanhao Yin
Liyan Zhou
Jianxin Xue
Min Ren

Frontiers in Immunology

doi 10.3389/fimmu.2025.1523455

998 views

Original Research

Published on 27 Jan 2025

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature

in Cancer Immunity and Immunotherapy

Yong Huang
Huibin Li
Zhifu Wei
Wanshan He
Bin Chen
Shuang Cheng
Zhifang Zhao
Lv Deng
Xiaohua Chen
Yu Lin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1492541

811 views

Navigation group

Articles

Interpretable machine learning and radiomics in hip MRI diagnostics: comparing ONFH and OA predictions to experts

SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma

Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II

Peripheral blood immunoinflammatory biomarkers: prospective predictors of postoperative long-term survival and chronic postsurgical pain in breast cancer

Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development

Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer

Sinonasal small-cell carcinoma combined concurrently with small-cell lung carcinoma: case report and literature review

Recent advances in the role of high-salt diet in anti- and pro-cancer progression

Radiomics-based biomarker for PD-1 status and prognosis analysis in patients with HCC

Neoadjuvant Sintilimab and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial

Prospect of Extracellular Vesicles in Tumor Immunotherapy

Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation

Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma

A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer

Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature